Augmentin 875 mg/125 mg filmsko obložene tablete סלובניה - סלובנית - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

augmentin 875 mg/125 mg filmsko obložene tablete

gsk d.o.o., ljubljana - amoksicilin; klavulanska kislina - filmsko obložena tableta - amoksicilin 875 mg / 1 tableta  klavulanska kislina125 mg / 1 tableta; klavulanska kislina 125 mg / 1 tableta - amoksicilin in zaviralec laktamaz beta

Vantobra האיחוד האירופי - סלובנית - EMA (European Medicines Agency)

vantobra

pari pharma gmbh - tobramycin - cystic fibrosis; respiratory tract infections - antibacterials za sistemsko uporabo , aminoglycoside antibacterials - zdravilo vantobra je indicirano za zdravljenje kronične pljučne infekcije zaradi pseudomonas aeruginosa pri bolnikih, starih 6 let ali več, s cistično fibrozo (cf). upoštevati je treba uradne smernice za ustrezno uporabo protibakterijsko agenti.

Lenalidomide Krka (previously Lenalidomide Krka d.d. Novo mesto) האיחוד האירופי - סלובנית - EMA (European Medicines Agency)

lenalidomide krka (previously lenalidomide krka d.d. novo mesto)

krka, d.d., novo mesto  - lenalidomide hydrochloride monohydrate - multiple myeloma; myelodysplastic syndromes; lymphoma, follicular; lymphoma, mantle-cell - imunosupresivi - multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indiciran za zdravljenje odraslih bolnikov s predhodno nezdravljenih več plazmocitom, ki niso primerni za presaditev. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 in 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a). multiple myelomalenalidomide krka as monotherapy is indicated for the maintenance treatment of adult patients with newly diagnosed multiple myeloma who have undergone autologous stem cell transplantation. lenalidomide krka as combination therapy with dexamethasone, or bortezomib and dexamethasone, or melphalan and prednisone (see section 4. 2) je indiciran za zdravljenje odraslih bolnikov s predhodno nezdravljenih več plazmocitom, ki niso primerni za presaditev. lenalidomide krka in combination with dexamethasone is indicated for the treatment of multiple myeloma in adult patients who have received at least one prior therapy. myelodysplastic syndromeslenalidomide krka as monotherapy is indicated for the treatment of adult patients with transfusion-dependent anemia due to low- or intermediate-1-risk myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality when other therapeutic options are insufficient or inadequate. mantle cell lymphomalenalidomide krka as monotherapy is indicated for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (see sections 4. 4 in 5. follicular lymphomalenalidomide krka in combination with rituximab (anti-cd20 antibody) is indicated for the treatment of adult patients with previously treated follicular lymphoma (grade 1 – 3a).

Glukoza Fresenius 100 mg/ml raztopina za infundiranje סלובניה - סלובנית - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glukoza fresenius 100 mg/ml raztopina za infundiranje

glukoza, brezvodna - raztopina za infundiranje - glukoza, brezvodna 100 mg / 1 ml - ogljikovi hidrati

Glukoza Fresenius 100 mg/ml raztopina za infundiranje סלובניה - סלובנית - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glukoza fresenius 100 mg/ml raztopina za infundiranje

glukoza, brezvodna - raztopina za infundiranje - glukoza, brezvodna 100 mg / 1 ml - ogljikovi hidrati

Glukoza Fresenius 100 mg/ml raztopina za infundiranje סלובניה - סלובנית - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glukoza fresenius 100 mg/ml raztopina za infundiranje

glukoza, brezvodna - raztopina za infundiranje - glukoza, brezvodna 100 mg / 1 ml - ogljikovi hidrati

Glukoza Fresenius 100 mg/ml raztopina za infundiranje סלובניה - סלובנית - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glukoza fresenius 100 mg/ml raztopina za infundiranje

glukoza, brezvodna - raztopina za infundiranje - glukoza, brezvodna 100 mg / 1 ml - ogljikovi hidrati

Glukoza Fresenius 50 mg/ml raztopina za infundiranje סלובניה - סלובנית - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glukoza fresenius 50 mg/ml raztopina za infundiranje

glukoza, brezvodna - raztopina za infundiranje - glukoza, brezvodna 50 mg / 1 ml - ogljikovi hidrati

Glukoza Fresenius 50 mg/ml raztopina za infundiranje סלובניה - סלובנית - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glukoza fresenius 50 mg/ml raztopina za infundiranje

glukoza, brezvodna - raztopina za infundiranje - glukoza, brezvodna 50 mg / 1 ml - ogljikovi hidrati

Glukoza Fresenius 50 mg/ml raztopina za infundiranje סלובניה - סלובנית - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

glukoza fresenius 50 mg/ml raztopina za infundiranje

glukoza, brezvodna - raztopina za infundiranje - glukoza, brezvodna 50 mg / 1 ml - ogljikovi hidrati